Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
Oncology for the Inquisitive Mind
Michael Fernando and Josh Hurwitz
🎙️ Science News Daily | Peer Review'd
Peer Review'd
The Human Risk Podcast
Human Risk
The Sadhguru Podcast - Of Mystics and Mistakes
Sadhguru Official
ABA on Tap
Mike Rubio, BCBA & Dan Lowery, BCBA (co-Hosts) & Suzanne Juzwik, BCBA (Producer)
Science & Futurism with Isaac Arthur
Isaac Arthur
Буде тобі наука
Kunsht/Куншт
The Climate Question
BBC World Service
Podcast Agro Pintar
Choon Kiat Lim
Humanism Now | Secular Ethics, Curiosity and Compassionate Change
Humanise Live
The Pod Universe with Dylan & Dalton
Dalton Deschain & Dylan Roth
Oral-Maxillofacial Surgery Insights
Bruce A. Huberman DMD
David A. Hughes
Resisting the Global Technocratic Coup One Person at a Time
The Automated Daily - Space News Edition
TrendTeller
That UFO Podcast
That UFO Podcast
HootPODS: Smart Stories & Curious Podcasts for Kids
HootPods
סקירת עיתונות ברפואה פנימית
פרופ' יהונתן שרעבי, שיבא
Eye On The Sky
Vermont Public
Your Astrological Energy
Kmet Radio
天方烨谈
基因频道
The Deep View: Conversations
The Deep View
Artificial Intelligence Masterclass
AI Masterclass
After Skool
After Skool
:format(jpeg)/https://f303.pmo.ee/OufvxC06GRmalHacQ3L5ZqekVRjaCYvo2oqOmfmH.png)
Vaba Akadeemia
Postimees podcast Raadio
Russian Rulers History Podcast
Mark Schauss
Totality Talks - The Solar Eclipse Podcast
Leticia Ferrer and Chris Alexander
Raum & Zeit
Tim Vollert & Maximilian Bensinger
Seventy3
任雨山
Accès au Marché Mondial des Dispositifs Médicaux
Pure Global
Глобальный доступ на рынок медицинских изделий
Pure Global
चिकित्सा उपकरण वैश्विक बाजार पहुंच
Pure Global
Tıbbi Cihazlar Küresel Pazar Erişimi
Pure Global
Akses Pasar Global Alat Kesehatan
Pure Global
Sophie Aldred's Ace Odyssey
Sophie Aldred
In Tune to Nature Podcast
cpfreeman
WHO Corner to Corner | Doctor Who Podcast
WHO C2C
HAUNTED: The Audio Drama
Impala Films
Science
Michael Fernando and Josh Hurwitz
This week, Josh and Michael's ASCO 2026 coverage looks at "Agents of the Future", trials of intrigue, promise and potential beyond its status. This episode also sheds light on more orphan status cancers like head and nec...
ASCO 2026 is done, and Michael and Josh have created a marathon episode for you all. This week we cover "Agents of the Present", where we summarise all the important trials with updates, overall survival and progression-...
This week, we take a quick trip to Stockholm, Sweden, where ESTRO (European Society for Radiotherapy and Oncology) took place several weeks ago. A/Prof Steven David digs deep into the latest updates in the breast cancer ...
This episode tells the story of how one man, Jake Messier, who is living with metastatic male breast cancer, is challenging the stigma surrounding this disease, which affects 1% of all breast cancer patients. It's an imp...
This week, we take a "back to the future" look at the early-stage pancreatic cancer phase, a relatively stagnant area in terms of pivotal trials. The two trials are the ESPAC4 trial, which examines doublet chemotherapy i...
Today, we accidentally skipped early pancreatic cancer and jumped straight to advanced pancreatic cancer. It was a sombre episode, with clinicians and advocates screaming for better treatment options for this cancer. Whi...
On today's episode, Josh and Michael "advance" in their ongoing GI journey, as Michael continuously insists on saying, to discuss advanced gastric and GOJ cancer. Historically, an orphan disease with a very poor prognosi...
This week, as we enter our 200th episode, Michael and Josh continue their journey through the alimentary canal, exploring the world of stomach cancer. Gastric cancer has been notoriously difficult to treat, with a thirty...
Good therapeutic options for metastatic colorectal cancer are limited after the fluoropyrimidine-based options are exhausted. This week, we explore the role of trifluridine-tipiracil (Lonsurf) and bevacizumab (VEGF inhib...
Today's episode, like several of the greatest cult classics, comes a bit earlier than anticipated. Before we wrap up our epic recap of the colorectal space, we will give you a little taster of our UGI series with a look ...
Metastatic Colorectal Cancer has a dearth of targetable mutations that have effective outcomes. This week, Michael and Josh see whether the wonder drug (trastruzumab deruxtecan) works in HER2-expressing colorectal cancer...
UPDATED WITH CORRECT AUDIOWhile Michael daydreams of getting a haircut, this week's topics are slightly more conventional as we explore the role of more targeted agents in metastatic colorectal cancer. KRAS and BRAF muta...
Historically, colorectal cancer treatment has been fairly standard, but this has shifted over the past decade with the introduction of targeted therapies. This week, our focus is on patients with microsatellite instabili...
Metastatic colorectal cancer is one of the leading causes of cancer-related deaths and among the most common types of cancer worldwide. Chemotherapy remains the main treatment, but the question is: how can we make it mor...
Professor Jonathan E. Rosenberg, MD, serves as the Chief of the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Centre (MSKCC). He is a prolific researcher and author, holding multiple titles including ...
The DYNAMIC duo are back, with Michael climbing the "Everest" of oncology and exploring the role of CTDNA in stage two colorectal cancer. Josh has the easier job of exploring neoadjuvant immunotherapy (ipilimumab and niv...
This week, we explore early colorectal cancer. Maybe it’s just this week, but there were plenty of “IDEAS” around. Michael highlights the importance of choosing an appropriate adjuvant regimen, whether that be FOLFOX or ...
Mesothelioma can strike at any time, but it most commonly affects those in their 70s, with cases continuing well into the 2030s. The time from exposure to diagnosis can be up to 60 years. This week, we explore treatment ...
This week, we return to our regular programming with a back-to-basics exploration of extensive small-cell lung cancer. A notorious killer and an aggressive type of lung cancer, it has seen new treatments developed at a f...
Today, our guest is a transformative figure in bowel cancer treatment. Professor Jenny Seligmann, a Consultant Medical Oncologist and Professor of Gastrointestinal and Translational Oncology at the University of Leeds, i...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.